Alnylam Pharmaceuticals, Inc.

NASDAQ (USD): Alnylam Pharmaceuticals, Inc. (ALNY)

Last Price

274.91

Today's Change

+0.34 (0.12%)

Day's Change

271.75 - 276.07

Trading Volume

453,982

Financial

Reported Currency in USD
Show?
Last 10 FY Result (Thousand)
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
Revenue 1,828,292 1,037,418 844,287 492,853 219,750 74,908 89,912 47,159 41,097 50,561 48.94%
PBT -433,517 -1,126,993 -852,144 -855,600 -885,253 -760,674 -490,874 -410,108 -290,073 -400,604 0.88%
Tax 6,725 4,163 680 2,681 863 823 -25,603 -23,438 -24,909 -40,209 -
NP -440,242 -1,131,156 -852,824 -858,281 -886,116 -761,497 -490,874 -410,108 -290,073 -360,395 2.24%
Tax Rate - - - - - - - - - - -
Total Cost 2,268,534 2,168,574 1,697,111 1,351,134 1,105,866 836,405 580,786 457,267 331,170 410,956 20.88%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
NP Margin -24.08 -109.04 -101.01 -174.15 -403.24 -1,016.58 -545.95 -869.63 -705.83 -712.79 -31.35%
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 31/12/14 CAGR
EPS -3.52 -9.30 -7.20 -7.46 -8.11 -7.57 -5.42 -4.79 -3.45 -4.85 -3.49%
EPS Diluted -3.52 -9.30 -7.20 -7.46 -8.11 -7.57 -5.42 -4.79 -3.45 -4.85 -3.49%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment